The UTI Core Laboratory will provide necessary cell culture, microbiological and molecular typing procedures for all four projects in the Program. Centralized performance of these specialized procedures assures their availability, high quality, and reduced cost. The following services will be provided: (1) Microbiological procedures for the isolation and characterization of E. coli and Lactobacillus in Projects 1 and 3. (2) Culture of (a) primary transitional epithelial cells for use in studies of the regulation of glycosphingolipid synthesis, bacterial adherence, and cytokine production described in Projects 2, 3, and 4; and (b) bladder organ structures consisting of primary bladder muscle co- cultured with transitional epithelial cells to form tubularized structures to be used as an in vitro model for catheter infections in Project 3. (3) The application of molecular typing techniques, including ribotyping and methods of detecting restriction fragment length polymorphism, to test for genetic relatedness among vaginal and urinary E. coli isolates serially collected from patients enrolled in the studies described in Project 1. (4) Use of molecular genetic techniques, including polymerase chain reaction and hybridization of colony blots with specific DNA probes to test uropathogenic E. coli collected from women with symptomatic UTI in Project 1 for previously recognized urovirulence determinants of E. coli as well as newly identified virulence factors found in Project 3. (5) Maintenance of existing collections of uropathogenic E. coli strains and Lactobacillus isolates and establishment of additional collections of these species as well as establishment of a P. aeruginosa strains bank to support Projects 1, 2, 3, and 4.

Project Start
2002-02-01
Project End
2003-01-31
Budget Start
Budget End
Support Year
5
Fiscal Year
2002
Total Cost
$211,312
Indirect Cost
Name
University of Washington
Department
Type
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Steigedal, Magnus; Marstad, Anne; Haug, Markus et al. (2014) Lipocalin 2 imparts selective pressure on bacterial growth in the bladder and is elevated in women with urinary tract infection. J Immunol 193:6081-9
Stapleton, Ann E (2013) Cranberry-containing products are associated with a protective effect against urinary tract infections. Evid Based Med 18:110-1
Hooton, Thomas M; Roberts, Pacita L; Cox, Marsha E et al. (2013) Voided midstream urine culture and acute cystitis in premenopausal women. N Engl J Med 369:1883-91
Bateman, Stacey L; Stapleton, Ann E; Stamm, Walter E et al. (2013) The type 1 pili regulator gene fimX and pathogenicity island PAI-X as molecular markers of uropathogenic Escherichia coli. Microbiology 159:1606-17
Stapleton, Ann E; Dziura, James; Hooton, Thomas M et al. (2012) Recurrent urinary tract infection and urinary Escherichia coli in women ingesting cranberry juice daily: a randomized controlled trial. Mayo Clin Proc 87:143-50
Chaturvedi, Kaveri S; Hung, Chia S; Crowley, Jan R et al. (2012) The siderophore yersiniabactin binds copper to protect pathogens during infection. Nat Chem Biol 8:731-6
Hooton, Thomas M; Roberts, Pacita L; Stapleton, Ann E (2012) Cefpodoxime vs ciprofloxacin for short-course treatment of acute uncomplicated cystitis: a randomized trial. JAMA 307:583-9
Spurbeck, Rachel R; Dinh Jr, Paul C; Walk, Seth T et al. (2012) Escherichia coli isolates that carry vat, fyuA, chuA, and yfcV efficiently colonize the urinary tract. Infect Immun 80:4115-22
Vigil, Patrick D; Stapleton, Ann E; Johnson, James R et al. (2011) Presence of putative repeat-in-toxin gene tosA in Escherichia coli predicts successful colonization of the urinary tract. MBio 2:e00066-11
Spurbeck, Rachel R; Stapleton, Ann E; Johnson, James R et al. (2011) Fimbrial profiles predict virulence of uropathogenic Escherichia coli strains: contribution of ygi and yad fimbriae. Infect Immun 79:4753-63

Showing the most recent 10 out of 50 publications